Skip to main content
Premium Trial:

Request an Annual Quote

CombiMatrix Stock to Join Russell Microcap Index

NEW YORK (GenomeWeb News) – CombiMatrix said today that its shares will be part of the Russell Microcap Index when it is reconstituted on June 27.
 
The Russell indexes include the 4,000 largest US stocks, ranked by market cap, as of the end of May each year. Those firms are included in either the Russell 3000 Index or the Russell Microcap.
 
Amit Kumar, president and CEO of CombiMatrix, said that the firm’s pending inclusion in the index “is a recognition of the continued development of our company.”
 
CombiMatrix currently has a market capitalization of around $57.8 million.
 

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.